UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Poor budgeting can trigger debt spirals and eventual bankruptcy if left unchecked. Learn how disciplined budgeting helps protect assets and secure your financial future.
27,895 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A 68-year-old couple has relied on an 8% yield from a long-held closed-end fund for over a decade, sparking debate am...
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...
In the AI inference era, memory and efficiency win more than raw compute. This sleeping semiconductor giant sits pois...
NVIDIA’s latest announcements are stirring chatter about AI-driven growth and new catalysts. Here’s what investors sh...
As inflation and market volatility persist into 2026, two smart social security claiming strategies help married coup...
Investors want to know where will amazon stock head in three years. This article breaks down AWS growth, AI investmen...
A rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
CrowdStrike is moving to a 4-for-1 stock split. This guide breaks down what the split does, how it affects you as an ...
A routine voicemail from a faux sheriff’s officer could cost families thousands. This guide explains how the 'lieuten...
A Mission Produce director just bought a multi-million-dollar stake in AVO. This article breaks down what insider buy...
Regulators in Spain are sending a clear message: there will be no extensions for the EU crypto licensing deadline. Th...